These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10899808)

  • 1. Velo-cardio-facial syndrome: a distinctive behavioral phenotype.
    Shprintzen RJ
    Ment Retard Dev Disabil Res Rev; 2000; 6(2):142-7. PubMed ID: 10899808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confirmation that the velo-cardio-facial syndrome is associated with haplo-insufficiency of genes at chromosome 22q11.
    Kelly D; Goldberg R; Wilson D; Lindsay E; Carey A; Goodship J; Burn J; Cross I; Shprintzen RJ; Scambler PJ
    Am J Med Genet; 1993 Feb; 45(3):308-12. PubMed ID: 8434616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome.
    Lachman HM; Morrow B; Shprintzen R; Veit S; Parsia SS; Faedda G; Goldberg R; Kucherlapati R; Papolos DF
    Am J Med Genet; 1996 Sep; 67(5):468-72. PubMed ID: 8886163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological, learning and psychosocial profile of primary school aged children with the velo-cardio-facial syndrome (22q11 deletion): evidence for a nonverbal learning disability?
    Swillen A; Vandeputte L; Cracco J; Maes B; Ghesquière P; Devriendt K; Fryns JP
    Child Neuropsychol; 1999 Dec; 5(4):230-41. PubMed ID: 10925707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Velo-cardio-facial syndrome: a review of 120 patients.
    Goldberg R; Motzkin B; Marion R; Scambler PJ; Shprintzen RJ
    Am J Med Genet; 1993 Feb; 45(3):313-9. PubMed ID: 8434617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome.
    Driscoll DA; Spinner NB; Budarf ML; McDonald-McGinn DM; Zackai EH; Goldberg RB; Shprintzen RJ; Saal HM; Zonana J; Jones MC
    Am J Med Genet; 1992 Sep; 44(2):261-8. PubMed ID: 1360769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voltage-gated calcium channel gamma 2 subunit gene is not deleted in velo-cardio-facial syndrome.
    Black JL; Krahn LE; Jalal SM
    Mol Psychiatry; 2001 Jul; 6(4):461-4. PubMed ID: 11443534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psychiatric disorders in velo-cardio-facial syndrome].
    Maesen A; Claes SJ; Neyrinck K
    Tijdschr Psychiatr; 2010; 52(1):51-6. PubMed ID: 20054797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome.
    Gothelf D; Schaer M; Eliez S
    Dev Disabil Res Rev; 2008; 14(1):59-68. PubMed ID: 18636637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The behavioural phenotype in velo-cardio-facial syndrome (VCFS): from infancy to adolescence.
    Swillen A; Devriendt K; Legius E; Prinzie P; Vogels A; Ghesquière P; Fryns JP
    Genet Couns; 1999; 10(1):79-88. PubMed ID: 10191433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annotation: velo-cardio-facial syndrome.
    Murphy KC
    J Child Psychol Psychiatry; 2005 Jun; 46(6):563-71. PubMed ID: 15877762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Velo-cardio-facial syndrome: language and psychological profiles.
    Golding-Kushner KJ; Weller G; Shprintzen RJ
    J Craniofac Genet Dev Biol; 1985; 5(3):259-66. PubMed ID: 4044789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Velo-cardio-facial syndrome: guidelines for diagnosis, treatment and follow-up of ent manifestations.
    Vantrappen G; Rommel N; Swillen A; Cremers CW; Fryns JP; Devriendt K
    Acta Otorhinolaryngol Belg; 2003; 57(2):101-6. PubMed ID: 12836465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of a human gene containing a nuclear localization signal from the critical region for velo-cardio-facial syndrome on 22q11.
    Funke B; Puech A; Saint-Jore B; Pandita R; Skoultchi A; Morrow B
    Genomics; 1998 Oct; 53(2):146-54. PubMed ID: 9790763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Children with a 22q11 deletion versus children with a speech-language impairment and learning disability: behavior during primary school age.
    Swillen A; Devriendt K; Ghesquière P; Fryns JP
    Genet Couns; 2001; 12(4):309-17. PubMed ID: 11837599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular analysis of velo-cardio-facial syndrome patients with psychiatric disorders.
    Carlson C; Papolos D; Pandita RK; Faedda GL; Veit S; Goldberg R; Shprintzen R; Kucherlapati R; Morrow B
    Am J Hum Genet; 1997 Apr; 60(4):851-9. PubMed ID: 9106531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features in 130 patients with the velo-cardio-facial syndrome. The Leuven experience.
    Vantrappen G; Rommel N; Devriendt K; Cremers CW; Feenstra L; Fryns JP
    Acta Otorhinolaryngol Belg; 2001; 55(1):43-8. PubMed ID: 11256191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scoliosis in velo-cardio-facial syndrome.
    Morava E; Lacassie Y; King A; Illes T; Marble M
    J Pediatr Orthop; 2002; 22(6):780-3. PubMed ID: 12409907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personality profiles of youngsters with velo-cardio-facial syndrome.
    Prinzie P; Swillen A; Vogels A; Kockuyt V; Curfs L; Haselager G; Hellinckx W; Devriendt K; Onghena P; Van Lieshout CF; Fryns JP
    Genet Couns; 2002; 13(3):265-80. PubMed ID: 12416634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients.
    Carlson C; Sirotkin H; Pandita R; Goldberg R; McKie J; Wadey R; Patanjali SR; Weissman SM; Anyane-Yeboa K; Warburton D; Scambler P; Shprintzen R; Kucherlapati R; Morrow BE
    Am J Hum Genet; 1997 Sep; 61(3):620-9. PubMed ID: 9326327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.